CRH agreed on June 22, 2026 to acquire Arcosa in an all-cash deal valued at $8.5 billion, according to The Wall Street Journal. The company is paying 11.5x Arcosa's projected 2026 earnings — a multiple that reflects both the scarcity value of quality aggregate reserves and the sustained appetite for consolidation among large building materials groups. Arcosa shares rose 7.4% to $146 in premarket trading. J.P. Morgan and Morgan Stanley are advising; the deal is expected to close in Q1 2027, pending regulatory and shareholder approval.

At 11.5x forward earnings, the price is not lean. Aggregates and infrastructure-products businesses typically trade across a wide range depending on the quality of reserves, how densely they cluster geographically, and how locked-in their customer contracts are. This multiple suggests CRH is paying for more than just current cash flow. Arcosa's portfolio spans construction products, engineered structures, and transportation goods — exposing CRH to U.S. infrastructure spending in segments where it had limited footprint before.

Arcosa's Own Acquisition Trail

Arcosa did not arrive at the table empty-handed. The company has been an active buyer itself, and its 2020 purchase of Cherry Companies illustrates the strategy. Arcosa closed that deal on January 6, 2020 for $298 million, acquiring a Texas-based business with roughly $176 million in annual revenue and about $37 million in EBITDA — an entry price of around 8x EBITDA, per Arcosa's investor release. Cherry bolstered Arcosa's construction products by adding aggregates and site development operations in the Southwest.

The math is worth watching. CRH is paying 11.5x 2026 earnings for the whole company — meaningfully richer than what Arcosa paid for bolt-on regional deals like Cherry. That gap is normal when a buyer acquires an entire platform versus when a platform company acquires a single asset. But it also shows how much value Arcosa created by stitching together regional businesses at lower entry multiples, improving operations, and riding the tailwind of U.S. infrastructure spending.

Scale and Strategic Fit

CRH is already one of the world's largest building materials suppliers by revenue, with a primary listing on the New York Stock Exchange after relocating its tax domicile in 2023. The Arcosa deal expands its U.S. operations into segments — engineered structures, barges, and construction aggregates across the South and Southwest — where it previously had little direct presence. The strategic fit is clearer: more market share and product density in the U.S., where CRH has been concentrating investment since the 2023 redomicile.

For Arcosa shareholders, the 7.4% jump in premarket trading is the market's initial gauge of the premium built into the offer. Whether regulators clear the deal without forcing divestitures remains the critical path item before the Q1 2027 close. Building materials deals have drawn sharper antitrust scrutiny in recent years, especially in regional aggregate markets where competitors overlap.

The all-cash structure avoids issuing new CRH shares to buy Arcosa and saves Arcosa shareholders from equity market timing risk. However, it does require CRH to either draw down its balance sheet or borrow substantial sums — and in today's environment, the cost of investment-grade debt is meaningful.

At $8.5 billion, this transaction ranks among the larger deals in global building materials in recent memory. The combination of scale, all-cash terms, and the backdrop of U.S. infrastructure investment makes the deal sensible. What matters for observers is that at 11.5x earnings, much of that infrastructure spending boost is already priced in.